Delhi High Court directed the Adovocates Community in Delhi to appeal for IPAB Centers at Mumbai, Delhi and Kolkatta to avoid the logistical delays in resolving disputes as IPAB's documents need to be transferred from the main centre in Chennai to these cities.
In a decision dated 21st August 2020 IPAB vide its Order has allowed an appeal and granted Patent to Appellant M/s. PFIZER PRODUCTS INC., USA for Tofacitinib and its salts. The appeal is against the order dated 3 rd September 2015 passed by the Controller of Patents under Section 15 of the Indian Patents Act, whereby the Appellant’s Indian patent application no. 00991/MUMNP/2003 was rejected on the ground that it is hit by section 13(1)(b) and being non-patentable under section 3(d). The Appellant requested for an urgent hearing of the matter and IPAB considered the request for urgent hearing and passed the present order. This Patent application claimed the compound 3-{(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piper...
Comments
Post a Comment